Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Clinical trial NCT05635045 · COMPLETED
Trial details
- NCT number
- NCT05635045
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2024-05-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.